There is one study that observed a decrease in serum levels of sRAGE and esRAGE (endogenous secretory receptor for AGEs, generated through alternative splicing of RAGE mRNA) by 32.4% (p = 0.004) when treating patients with multiple sclerosis with fingolimod for 12 months. This evidence concerns the gene AGER and multiple sclerosis.